Cargando…

Galunisertib Exerts Antifibrotic Effects on TGF-β-Induced Fibroproliferative Dermal Fibroblasts

Dermal fibroblasts in pathological scars secrete constitutively elevated levels of TGF-β, signaling the transcription of fibrotic genes via activin-like kinase 5 (ALK5). In the present study, we examine the antifibrotic effects of galunisertib, a small-molecule inhibitor of ALK5, on fibroproliferati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peterson, Joshua M., Jay, Jayson W., Wang, Ye, Joglar, Alejandro A., Prasai, Anesh, Palackic, Alen, Wolf, Steven E., El Ayadi, Amina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223605/ https://www.ncbi.nlm.nih.gov/pubmed/35743131 http://dx.doi.org/10.3390/ijms23126689

Ejemplares similares

Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring
por: El Ayadi, Amina, et al.
Publicado: (2020)

Therapeutic Strategies to Reduce Burn Wound Conversion
por: Palackic, Alen, et al.
Publicado: (2022)

Comparing the Effectiveness of Glucocorticoids in Preventing Hypertrophic Scar Diagnosis in Burn Patients
por: Joglar, Alejandro, et al.
Publicado: (2023)

Collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models
por: Shen, Zhu, et al.
Publicado: (2021)

Erratum to collagen triple helix repeat containing-1 exerts antifibrotic effects on human skin fibroblast and bleomycin-induced dermal fibrosis models
Publicado: (2022)

Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model
por: Higuchi, Tomoaki, et al.
Publicado: (2023)

505 Risk Stratification by TBSA for Acute Kidney Injury in Burn Patients Following Combination Antibiotic Therapy
por: Brondeel, Kimberley, et al.
Publicado: (2023)

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine
por: Capper, David, et al.
Publicado: (2017)

Syndecan-2 regulates PAD2 to exert antifibrotic effects on RA-ILD fibroblasts
por: Tsoyi, Konstantin, et al.
Publicado: (2022)

Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves’ Ophthalmopathy by Targeting Orbital Fibroblasts
por: Yang, Shenglan, et al.
Publicado: (2022)

Antifibrotic effects of eupatilin on TGF-β1-treated human vocal fold fibroblasts
por: Park, Sung Joon, et al.
Publicado: (2021)

Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves’ Orbitopathy
por: Wang, Xing, et al.
Publicado: (2022)

Biventricular differences in β-adrenergic receptor signaling following burn injury
por: Guillory, Ashley N., et al.
Publicado: (2017)

Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
por: Giannelli, Gianluigi, et al.
Publicado: (2020)

Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?
por: Huang, Xin, et al.
Publicado: (2021)

Evaluating the fibroproliferative response to ventilator-induced lung injury
por: Curley, G, et al.
Publicado: (2010)

Biomarkers of Fibroproliferative Healing in Fibrosing Idiopathic Interstitial Pneumonias
por: Vasakova, Martina, et al.
Publicado: (2012)

NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC
por: Cao, Yuan, et al.
Publicado: (2017)

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Publicado: (2020)

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
por: Giannelli, Gianluigi, et al.
Publicado: (2021)

Antifibrotic Effects of Roscovitine in Normal and Scleroderma Fibroblasts
por: Steinman, Richard A., et al.
Publicado: (2012)

Radiosensitizing effect of galunisertib, a TGF-ß receptor I inhibitor, on head and neck squamous cell carcinoma in vitro
por: Jank, Bernhard J., et al.
Publicado: (2022)

Trial by CCN2: a standardized test for fibroproliferative disease?
por: Leask, Andrew
Publicado: (2009)

Notch Intracellular Domain Expression in Various Skin Fibroproliferative Diseases
por: Kim, Jung-Eun, et al.
Publicado: (2014)

Enhanced production of IGF‐I in the lungs of fibroproliferative ARDS patients
por: Andonegui, Graciela, et al.
Publicado: (2014)

Evidence of selection as a cause for racial disparities in fibroproliferative disease
por: Hellwege, Jacklyn N., et al.
Publicado: (2017)

Renalase Challenges the Oxidative Stress and Fibroproliferative Response in COVID-19
por: Stojanovic, Dijana, et al.
Publicado: (2022)

Local, Quantitative Morphometry of Fibroproliferative Lung Injury using Laminin
por: Cox, Brendan P., et al.
Publicado: (2023)

Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts
por: Maier, Armin, et al.
Publicado: (2015)

Galunisertib inhibits glioma vasculogenic mimicry formation induced by astrocytes
por: Zhang, Chao, et al.
Publicado: (2016)

Galunisertib enhances chimeric antigen receptor-modified T cell function
por: Wang, Zhixiong, et al.
Publicado: (2020)

Characterization of Adipose-Derived Stem Cells Following Burn Injury
por: Prasai, Anesh, et al.
Publicado: (2017)

Cafeteria Diet Impacts the Body Weight and Energy Expenditure of Brown Norway Rats in an Apparent Age Dependent Manner, but Has no Effect on Muscle Anabolic Sensitivity to Nutrition
por: El Ayadi, Amina, et al.
Publicado: (2021)

Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases
por: Russell, Shirley B., et al.
Publicado: (2015)

Comprehensive Ontology of Fibroproliferative Diseases: Protocol for a Semantic Technology Study
por: Golec, Marcin, et al.
Publicado: (2023)

Metal chelation reduces skin epithelial inflammation and rescues epithelial cells from toxicity due to thermal injury in a rat model
por: El Ayadi, Amina, et al.
Publicado: (2020)

A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
por: Kelley, R.K., et al.
Publicado: (2019)

The Extra Virgin Olive Oil Polyphenol Oleocanthal Exerts Antifibrotic Effects in the Liver
por: Gabbia, Daniela, et al.
Publicado: (2021)

Targeting the TGFβ pathway with galunisertib, a TGFβRI SMI, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint inhibition
por: Schaer, David, et al.
Publicado: (2015)

Apoptosis and Cell Proliferation Markers in Inflammatory-Fibroproliferative Diseases of the Vessel Wall (Review)
por: Klimentova, E.A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d4itbmmdfpafvjchs0k1c28d0o